For Immediate Release

Chicago, IL –July 8, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Arbor Realty Trust (ABR Quick QuoteABR - Free Report) , Geo Group Inc (The) (GEO Quick QuoteGEO - Free Report) , Ellington Financial LLC (EFC Quick QuoteEFC - Free Report) , Och-Ziff Capital Management Group LLC and PennyMac Mortgage Investment Trust (PMT Quick QuotePMT - Free Report) .

Here are highlights from Friday’s Analyst Blog:

5 Cheap Dividend Stocks for Uncertain Times Ahead

There are a number of things irking Mr. Market right now, including continuing trade tensions with China, declining consumer confidence, deflationary tendencies and delays/postponement of an interest rate cut that could breathe some life into it.

All of this is happening in a world of progressively greater efficiency, meaning that technology deployment and mechanization of processes is already stealing jobs. This situation can only exacerbate as automation is a must if we are to see the steady growth rates we hunger for.  

To make matters worse, there’s an imbalance in the housing market, where inventories of costlier dwellings are on the rise along with demand for cheaper housing.

So the need to invest wisely has never been more important as it is today. Because truly, everything that we have been depending on, like our jobs, homes and livelihoods are increasingly on the line.

One way of dealing with the situation is by hedging our bets. It’s already well known that riskier investments generate higher returns. But if you’re like me, you will be putting only a small part of your available funds into these things and parking the bulk of your resources into income generating investments. You could then reinvest the income or use the cash, depending on your needs.

So what kind of income-generating assets make the most sense? Obviously, those that appear undervalued with respect to the basket/group of stocks to which they belong. And in the vast ocean of stocks to choose from, obviously those industries/groups that have positive things (catalysts) going for them are more attractive than the others.

With these general thoughts in mind, I have picked a few stocks that have Buy ranks, are placed in attractive industries, those that are suitable for moderately risk-averse investors, those that have posted a big earnings beat in recent history, that pay out attractive dividends and are reasonably or attractively valued. So here’s the list-   

Arbor Realty Trust

Arbor Realty Trust is a specialized investor in real estate-related bridge and mezzanine loans, preferred equity, mortgage-related securities and other real estate-related assets. The following are key criteria that make it a Buy in this environment-

Zacks Rank #1 (Strong Buy)

REIT and Equity Trust – Other Industry Rank 79 (top 31%)

Growth Score B

Last quarter EPS surprise 22.2%

Dividend yield 9.2%                           

P/E based on forward earnings for the current year 9.94X (industry 16.60X)

Geo Group Inc (The)

The GEO Group is an equity real estate investment trust. It specializes in the design, development, financing and operation of correctional, detention and community re-entry facilities. It has operations in the U.S., Australia, South Africa and the UK. Important reasons to buy the stock are-

Zacks Rank #1

REIT and Equity Trust - Other Industry Rank 79 (top 31%)

VGM Score B

Last quarter EPS surprise 42.55%

Dividend yield 9.21% 

P/E based on forward earnings for the current year 7.79X (industry 16.60X)

Ellington Financial LLC

Ellington Financial is a finance company that acquires and manages mortgage-related assets, including residential mortgage-backed securities, prime jumbo, Alternative A-paper and subprime residential mortgage loans. The company's targeted assets also include mortgage-related derivatives, corporate debt and equity securities and derivatives. Key investment criteria include-

Zacks Rank #1

Financial - Mortgage & Related Services Industry Rank 19 (top 7%)

Momentum Score B

Last quarter EPS surprise 21.62%

Dividend yield 9.36% 

P/E based on forward earnings for the current year 10.65X (industry 18.90X)

Och-Ziff Capital Management Group LLC

Och-Ziff Capital Management Group is a leading, global institutional alternative asset management firm. It seeks to deliver consistent, positive, risk-adjusted returns throughout market cycles, with particular focus on risk management and capital preservation.

Its diversified, multi-strategy approach is based on global investment strategies spanning merger arbitrage, convertible arbitrage, equity restructuring, credit and distressed investments, private investments and real estate. The rationale for investment includes

Zacks Rank #2 (Buy)

Financial - Investment Management Industry Rank 99 (top 39%)

Value Score B

Last quarter EPS surprise 223.53%

Dividend yield 6.19% 

P/E based on forward earnings for the current year 12.72X (industry 36.90X)

PennyMac Mortgage Investment Trust

PennyMac Mortgage Investment Trust is a real estate investment trust. The company invests primarily in residential mortgage loans and mortgage-related assets, acquiring primarily troubled home mortgage loans and mortgage-backed securities from FDIC liquidations of failed banks, US Treasury Legacy Loans Program auctions, and direct acquisitions from mortgage and insurance companies and foreign banks. It promises risk-adjusted returns to investors over the long-term, primarily through dividends and secondarily through capital appreciation. Key investment criteria include

Zacks Rank #2

Real Estate - Operations Industry Rank 77 (top 30%)

VGM Score B

Last quarter EPS surprise 61.90%

Dividend yield 8.6%   

P/E based on forward earnings for the current year 10.62X (industry 10.60X)

You can also see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.